Although increased circulating GDF-15 levels have been closely associated with cardiometabolic disorder and cardiovascular disease [1,32,33], its elevation may also reflect insulin responsiveness [34] and the therapeutic effects of antidiabetic medications [35,36]. This evidence concerns the gene INS and cardiovascular disorder.